EstimizeAlerts,,2019-02-11 13:15:00,73.742,ABT analysts on Estimize are expecting 197 YoY revenue growth for Q1 down from 232 in Q4 Reporting 0417 BMOestimizecomintroabtchar
MS_Money_Moves,True,2019-02-11 12:25:00,73.75,MS is Swinging REPH Mex could be a threat to ACRX and TRVN and is not an opioid Dex approved in 90s by ABTmsmoneymovescom20190211
ChartMill,,2019-02-11 10:17:00,73.545,OHI ABT and SYNH are amongst the strongest stocks in the market nearing a new high chartmillcomstockscreener
DominantInvestorsApp,True,2019-02-11 09:51:00,73.49,ABT target price 8540 Forecast from Dominant investors app
